September 26, 2024

2 Minutes
Medicine

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease

Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company developing novel immunotherapeutic candidates that guide T cells to control disease, has announced the initiation of its first-in-human Phase 1 trial of VTP-1000 in adults with coeliac...
Read More